Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Japanese Council recommends approval of Crestor

Dec. 29, 2004

P&G withdraws Intrinsa NDA with plans to submit new application

Dec. 29, 2004

Pfizer team reports series of PPAR agonists for dyslipidemia, hypercholesteremia, etc.

Dec. 28, 2004

Bristol-Myers Squibb submits muraglitazar NDA

Dec. 28, 2004

IoGen enters pivotal phase III study for fibrocystic breast disease

Dec. 28, 2004

Dosing begins in phase II obesity study of APD-356

Dec. 28, 2004

Banyu describes compounds for the treatment of obesity

Dec. 27, 2004

Agents for the treatment of diabetes claimed by Taisho

Dec. 27, 2004

Novel 5-HMF prodrug prolongs antisickling effect in vivo

Dec. 27, 2004

CB1 receptor antagonists described by Pfizer

Dec. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...